Tempest Therapeutics Ownership 2024 | Who Owns Tempest Therapeutics Now?

OverviewFinancials Chart

Institutional Ownership

1.36%

Insider Ownership

0.24%

Retail Ownership

98.40%

Institutional Holders

7.00

Tempest Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLACKROCK INC.	2.47%	-	550,241	42,046	8.27%	1,205,028	Jun 30, 2024
FMR LLC	1.94%	0.00%	431,932	-50	-0.01%	945,931	Jun 30, 2024
VANGUARD GROUP INC	0.79%	-	176,193	-	-	385,862	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.69%	-	154,241	22,158	16.78%	337,830	Jun 30, 2024
FIL LTD	0.58%	0.00%	129,579	-	-	283,778	Jun 30, 2024
IKARIAN CAPITAL, LLC	0.47%	0.04%	105,600	-	-	231,264	Jun 30, 2024
GSA CAPITAL PARTNERS LLP	0.45%	0.02%	101,043	101,043	100.00%	221,000	Jun 30, 2024
MORGAN STANLEY	0.28%	-	62,736	25,945	70.52%	137,392	Jun 30, 2024
VIRTU FINANCIAL LLC	0.28%	0.01%	62,027	33,453	117.08%	136,000	Jun 30, 2024
DAVENPORT & CO LLC	0.22%	0.00%	50,000	50,000	100.00%	109,500	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.19%	-	43,257	228	0.53%	94,733	Jun 30, 2024
STATE STREET CORP	0.19%	-	41,492	-	-	90,867,000	Jun 30, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.	0.18%	0.00%	40,750	26,750	191.07%	89,243	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.11%	0.00%	25,378	-772	-2.95%	55,565	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.11%	-	25,084	25,084	100.00%	54,934	Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC	0.11%	0.00%	24,572	-	-	53,813	Jun 30, 2024
NORTHERN TRUST CORP	0.09%	-	20,354	-1	-0.00%	44,575,000	Jun 30, 2024
MAYTECH GLOBAL INVESTMENTS, LLC	0.04%	0.00%	10,000	10,000	100.00%	21,900	Jun 30, 2024
PARALLEL ADVISORS, LLC	0.00%	-	236	236	100.00%	517	Jun 30, 2024
CIBC PRIVATE WEALTH GROUP, LLC	0.00%	-	133	-	-	279	Jun 30, 2024

Tempest Therapeutics's largest institutional shareholder is BLACKROCK INC., holding 2.47% of the company's total share outstanding, currently valued at $1.21M. The top 10 institutional shareholders own together 8.20% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
IKARIAN CAPITAL, LLC	0.47%	0.04%	105,600	-	-	231,264	Jun 30, 2024
GSA CAPITAL PARTNERS LLP	0.45%	0.02%	101,043	101,043	100.00%	221,000	Jun 30, 2024
VIRTU FINANCIAL LLC	0.28%	0.01%	62,027	33,453	117.08%	136,000	Jun 30, 2024
MAYTECH GLOBAL INVESTMENTS, LLC	0.04%	0.00%	10,000	10,000	100.00%	21,900	Jun 30, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.	0.18%	0.00%	40,750	26,750	191.07%	89,243	Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC	0.11%	0.00%	24,572	-	-	53,813	Jun 30, 2024
DAVENPORT & CO LLC	0.22%	0.00%	50,000	50,000	100.00%	109,500	Jun 30, 2024
FIL LTD	0.58%	0.00%	129,579	-	-	283,778	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.11%	0.00%	25,378	-772	-2.95%	55,565	Jun 30, 2024
FMR LLC	1.94%	0.00%	431,932	-50	-0.01%	945,931	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.69%	-	154,241	22,158	16.78%	337,830	Jun 30, 2024
BLACKROCK INC.	2.47%	-	550,241	42,046	8.27%	1,205,028	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.11%	-	25,084	25,084	100.00%	54,934	Jun 30, 2024
PARALLEL ADVISORS, LLC	0.00%	-	236	236	100.00%	517	Jun 30, 2024
MORGAN STANLEY	0.28%	-	62,736	25,945	70.52%	137,392	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.19%	-	43,257	228	0.53%	94,733	Jun 30, 2024
NORTHERN TRUST CORP	0.09%	-	20,354	-1	-0.00%	44,575,000	Jun 30, 2024
VANGUARD GROUP INC	0.79%	-	176,193	-	-	385,862	Jun 30, 2024
STATE STREET CORP	0.19%	-	41,492	-	-	90,867,000	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.00%	-	15	-7,980	-99.81%	33	Jun 30, 2024

The largest Tempest Therapeutics shareholder by % of total assets is IKARIAN CAPITAL, LLC. The company owns 105.60K shares of Tempest Therapeutics (TPST), representing 0.04% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GSA CAPITAL PARTNERS LLP	0.45%	0.02%	101,043	101,043	100.00%	221,000	Jun 30, 2024
DAVENPORT & CO LLC	0.22%	0.00%	50,000	50,000	100.00%	109,500	Jun 30, 2024
BLACKROCK INC.	2.47%	-	550,241	42,046	8.27%	1,205,028	Jun 30, 2024
VIRTU FINANCIAL LLC	0.28%	0.01%	62,027	33,453	117.08%	136,000	Jun 30, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.	0.18%	0.00%	40,750	26,750	191.07%	89,243	Jun 30, 2024
MORGAN STANLEY	0.28%	-	62,736	25,945	70.52%	137,392	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.11%	-	25,084	25,084	100.00%	54,934	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.69%	-	154,241	22,158	16.78%	337,830	Jun 30, 2024
MAYTECH GLOBAL INVESTMENTS, LLC	0.04%	0.00%	10,000	10,000	100.00%	21,900	Jun 30, 2024
PARALLEL ADVISORS, LLC	0.00%	-	236	236	100.00%	517	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.19%	-	43,257	228	0.53%	94,733	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.00%	-	27	-	-	59	Jun 30, 2024
CIBC PRIVATE WEALTH GROUP, LLC	0.00%	-	133	-	-	279	Jun 30, 2024
STATE STREET CORP	0.19%	-	41,492	-	-	90,867,000	Jun 30, 2024
VANGUARD GROUP INC	0.79%	-	176,193	-	-	385,862	Jun 30, 2024
FIL LTD	0.58%	0.00%	129,579	-	-	283,778	Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC	0.11%	0.00%	24,572	-	-	53,813	Jun 30, 2024
IKARIAN CAPITAL, LLC	0.47%	0.04%	105,600	-	-	231,264	Jun 30, 2024
NORTHERN TRUST CORP	0.09%	-	20,354	-1	-0.00%	44,575,000	Jun 30, 2024
WHITTIER TRUST CO	-	-	-	-2	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Tempest Therapeutics's largest institutional buyer is GSA CAPITAL PARTNERS LLP. The company purchased 101.04K stocks of TPST, valued at $221.00K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SIMPLEX TRADING, LLC	-	-	-	-37,820	-100.00%	-	Jun 30, 2024
BANK OF MONTREAL /CAN/	-	-	-	-20,000	-100.00%	-	Jun 30, 2024
HRT FINANCIAL LP	-	-	-	-13,040	-100.00%	-	Jun 30, 2024
XTX TOPCO LTD	-	-	-	-10,773	-100.00%	-	Jun 30, 2024
GROUP ONE TRADING, L.P.	-	-	-	-10,685	-100.00%	-	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.00%	-	15	-7,980	-99.81%	33	Jun 30, 2024
UBS GROUP AG	-	-	-	-921	-100.00%	-	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.11%	0.00%	25,378	-772	-2.95%	55,565	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-98	-100.00%	-	Jun 30, 2024
FMR LLC	1.94%	0.00%	431,932	-50	-0.01%	945,931	Jun 30, 2024
WHITTIER TRUST CO OF NEVADA INC	-	-	-	-11	-100.00%	-	Jun 30, 2024
WHITTIER TRUST CO	-	-	-	-2	-100.00%	-	Jun 30, 2024
NORTHERN TRUST CORP	0.09%	-	20,354	-1	-0.00%	44,575,000	Jun 30, 2024
IKARIAN CAPITAL, LLC	0.47%	0.04%	105,600	-	-	231,264	Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC	0.11%	0.00%	24,572	-	-	53,813	Jun 30, 2024
FIL LTD	0.58%	0.00%	129,579	-	-	283,778	Jun 30, 2024
VANGUARD GROUP INC	0.79%	-	176,193	-	-	385,862	Jun 30, 2024
STATE STREET CORP	0.19%	-	41,492	-	-	90,867,000	Jun 30, 2024
CIBC PRIVATE WEALTH GROUP, LLC	0.00%	-	133	-	-	279	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.00%	-	27	-	-	59	Jun 30, 2024

As of Jun 30 2024, Tempest Therapeutics's biggest institutional seller is SIMPLEX TRADING, LLC. The company sold -37.82K shares of TPST, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GSA CAPITAL PARTNERS LLP	0.45%	0.02%	101,043	101,043	100.00%	221,000	Jun 30, 2024
DAVENPORT & CO LLC	0.22%	0.00%	50,000	50,000	100.00%	109,500	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.11%	-	25,084	25,084	100.00%	54,934	Jun 30, 2024
PARALLEL ADVISORS, LLC	0.00%	-	236	236	100.00%	517	Jun 30, 2024

Tempest Therapeutics's largest new institutional shareholder by number of shares is GSA CAPITAL PARTNERS LLP, purchased 101.04K shares, valued at $221.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SIMPLEX TRADING, LLC	-	-	-	-37,820	-100.00%	-	Jun 30, 2024
BANK OF MONTREAL /CAN/	-	-	-	-20,000	-100.00%	-	Jun 30, 2024
HRT FINANCIAL LP	-	-	-	-13,040	-100.00%	-	Jun 30, 2024
XTX TOPCO LTD	-	-	-	-10,773	-100.00%	-	Jun 30, 2024
GROUP ONE TRADING, L.P.	-	-	-	-10,685	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-921	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-98	-100.00%	-	Jun 30, 2024
WHITTIER TRUST CO OF NEVADA INC	-	-	-	-11	-100.00%	-	Jun 30, 2024
WHITTIER TRUST CO	-	-	-	-2	-100.00%	-	Jun 30, 2024

Tempest Therapeutics's largest sold out institutional shareholder by shares sold is SIMPLEX TRADING, LLC, sold -37.82K shares, valued at -, as of undefined.

Tempest Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY COMMONWEALTH TRUST	0.00%	8,933	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	121,597	31,944	35.63%	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	174,007	-174,007	-50.00%	Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	6,359	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	3,628	-	-	Feb 29, 2024
SUNAMERICA SERIES TRUST	0.00%	1,135	-	-	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	508	-	-	Jan 31, 2024
Dimensional ETF Trust	0.00%	800	-	-	Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	1,500	-	-	Jan 31, 2024
Legg Mason Global Asset Management Trust	0.00%	10,173	-	-	Jan 31, 2024

Tempest Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY COMMONWEALTH TRUST", owning 8.93K shares, compromising 0.00% of its total assets.

Tempest Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	7	-78.13%
31 Mar, 24	32	-11.11%
31 Dec, 23	36	50.00%
30 Sep, 23	24	9.09%
30 Jun, 23	22	29.41%
31 Mar, 23	17	30.77%
31 Dec, 22	13	-7.14%
30 Sep, 22	14	-6.67%
30 Jun, 22	15	15.38%
31 Mar, 22	13	-18.75%
31 Dec, 21	16	-15.79%
30 Sep, 21	19	-9.52%
30 Jun, 21	21	-

As of 30 Jun 24, 7 institutions are holding Tempest Therapeutics's shares, representing a decrease of -78.13% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	301,721	-83.82%
31 Mar, 24	1,864,298	-15.77%
31 Dec, 23	2,213,399	-35.12%
30 Sep, 23	3,411,773	-10.86%
30 Jun, 23	3,827,439	23.07%
31 Mar, 23	3,109,866	1.38%
31 Dec, 22	3,067,685	-0.44%
30 Sep, 22	3,081,180	-1.05%
30 Jun, 22	3,113,830	48.21%
31 Mar, 22	2,100,895	-10.59%
31 Dec, 21	2,349,772	7.28%
30 Sep, 21	2,190,289	19.36%
30 Jun, 21	1,835,086	-

Tempest Therapeutics (TPST) has 301.72K shares outstanding as of 30 Jun 24, down -83.82% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	1.36%	0.93%
31 Mar, 24	12.09%	4.92%
31 Dec, 23	15.67%	2.68%
30 Sep, 23	24.19%	3.13%
30 Jun, 23	27.81%	5.45%
31 Mar, 23	22.60%	3.20%
31 Dec, 22	26.56%	5.20%
30 Sep, 22	22.60%	3.12%
30 Jun, 22	26.91%	3.13%
31 Mar, 22	29.31%	2.40%
31 Dec, 21	34.98%	3.29%
30 Sep, 21	32.60%	4.37%
30 Jun, 21	27.32%	-

As of 30 Jun 24, Tempest Therapeutics is held by 1.36% institutional shareholders, representing a 0.93% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	6	-60.00%
31 Mar, 24	15	-42.31%
31 Dec, 23	26	225.00%
30 Sep, 23	8	-38.46%
30 Jun, 23	13	62.50%
31 Mar, 23	8	100.00%
31 Dec, 22	4	-
30 Sep, 22	4	-20.00%
30 Jun, 22	5	-
31 Mar, 22	5	-
31 Dec, 21	5	-58.33%
30 Sep, 21	12	-42.86%
30 Jun, 21	21	-

6 institutional shareholders have increased their position in TPST stock as of 30 Jun 24 compared to 15 in the previous quarter (a -60.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	-	-100.00%
31 Mar, 24	5	-
31 Dec, 23	5	-28.57%
30 Sep, 23	7	133.33%
30 Jun, 23	3	-
31 Mar, 23	3	50.00%
31 Dec, 22	2	-50.00%
30 Sep, 22	4	-20.00%
30 Jun, 22	5	66.67%
31 Mar, 22	3	-40.00%
31 Dec, 21	5	66.67%
30 Sep, 21	3	-
30 Jun, 21	-	-

- institutional shareholders have reduced their position in TPST stock as of 30 Jun 24 compared to 5 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	7	-78.13%	301,721	-83.82%	1.36%	0.93%	6	-60.00%	-	-100.00%
31 Mar, 24	32	-11.11%	1,864,298	-15.77%	12.09%	4.92%	15	-42.31%	5	-
31 Dec, 23	36	50.00%	2,213,399	-35.12%	15.67%	2.68%	26	225.00%	5	-28.57%
30 Sep, 23	24	9.09%	3,411,773	-10.86%	24.19%	3.13%	8	-38.46%	7	133.33%
30 Jun, 23	22	29.41%	3,827,439	23.07%	27.81%	5.45%	13	62.50%	3	-
31 Mar, 23	17	30.77%	3,109,866	1.38%	22.60%	3.20%	8	100.00%	3	50.00%
31 Dec, 22	13	-7.14%	3,067,685	-0.44%	26.56%	5.20%	4	-	2	-50.00%
30 Sep, 22	14	-6.67%	3,081,180	-1.05%	22.60%	3.12%	4	-20.00%	4	-20.00%
30 Jun, 22	15	15.38%	3,113,830	48.21%	26.91%	3.13%	5	-	5	66.67%
31 Mar, 22	13	-18.75%	2,100,895	-10.59%	29.31%	2.40%	5	-	3	-40.00%
31 Dec, 21	16	-15.79%	2,349,772	7.28%	34.98%	3.29%	5	-58.33%	5	66.67%
30 Sep, 21	19	-9.52%	2,190,289	19.36%	32.60%	4.37%	12	-42.86%	3	-
30 Jun, 21	21	-	1,835,086	-	27.32%	-	21	-	-	-

Tempest Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 12, 2024	Versant Venture Capital VI, L.P.	10 percent owner	-	S-Sale	Sell	400,000	$1.35	$540.04K	597,940
Aug 12, 2024	Versant Venture Capital VI, L.P.	10 percent owner	-	S-Sale	Sell	387,999	$1.10	$426.99K	209,941
Jul 08, 2024	Brady Stephen R	director, officer	President and CEO	P-Purchase	Buy	35,000	$2.11	$73.85K	46,376
Jul 03, 2024	Whiting Samuel	officer	Chief Medical Officer	P-Purchase	Buy	4,672	$2.13	$9.95K	9,573
Jul 02, 2024	Trojanowski Justin	officer	Corporate Controller	P-Purchase	Buy	7,500	$2.16	$16.20K	22,168

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 08, 2024	Brady Stephen R	director, officer	President and CEO	P-Purchase	Buy	35,000	$2.11	$73.85K	46,376
Jul 03, 2024	Whiting Samuel	officer	Chief Medical Officer	P-Purchase	Buy	4,672	$2.13	$9.95K	9,573
Jul 02, 2024	Trojanowski Justin	officer	Corporate Controller	P-Purchase	Buy	7,500	$2.16	$16.20K	22,168

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Aug 12, 2024	Versant Venture Capital VI, L.P.	10 percent owner	-	S-Sale	Sell	400,000	$1.35	$540.04K	597,940
Aug 12, 2024	Versant Venture Capital VI, L.P.	10 percent owner	-	S-Sale	Sell	387,999	$1.10	$426.99K	209,941

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 12, 2024	Versant Venture Capital VI, L.P.	10 percent owner	-	S-Sale	Sell	400,000	$1.35	$540.04K	597,940
Aug 12, 2024	Versant Venture Capital VI, L.P.	10 percent owner	-	S-Sale	Sell	387,999	$1.10	$426.99K	209,941
Jul 08, 2024	Brady Stephen R	director, officer	President and CEO	P-Purchase	Buy	35,000	$2.11	$73.85K	46,376
Jul 03, 2024	Whiting Samuel	officer	Chief Medical Officer	P-Purchase	Buy	4,672	$2.13	$9.95K	9,573
Jul 02, 2024	Trojanowski Justin	officer	Corporate Controller	P-Purchase	Buy	7,500	$2.16	$16.20K	22,168
Jun 14, 2024	Pellizzari Christine A	director	-	A-Award	Buy	16,000	$3.03	$48.48K	16,000
Jun 14, 2024	NICHOL GEOFFREY	director	-	A-Award	Buy	16,000	$3.03	$48.48K	16,000
Jun 14, 2024	Simantov Ronit	director	-	A-Award	Buy	16,000	$3.03	$48.48K	16,000
Jun 14, 2024	RAAB MICHAEL	director	-	A-Award	Buy	16,000	$3.03	$48.48K	16,000
Jan 05, 2024	Brady Stephen R	director, officer	President and CEO	A-Award	Buy	250,000	$4.66	$1.17M	250,000
Jan 05, 2024	Whiting Samuel	officer	Chief Medical Officer	A-Award	Buy	100,000	$4.66	$466.00K	100,000
Jan 05, 2024	Trojanowski Justin	officer	Principal Accounting Officer	A-Award	Buy	26,500	$4.66	$123.49K	26,500
Jan 05, 2024	Maestas Nicholas	officer	VP of Strategy and Finance	A-Award	Buy	40,000	$4.66	$186.40K	40,000
Oct 13, 2023	Brady Stephen R	director, officer	President and CEO	A-Award	Buy	725,000	$9.77	$7.08M	725,000
Oct 13, 2023	Trojanowski Justin	officer	Corporate Controller	A-Award	Buy	55,000	$9.77	$537.35K	55,000
Oct 13, 2023	Whiting Samuel	officer	Chief Medical Officer	A-Award	Buy	325,000	$9.77	$3.18M	325,000
Oct 13, 2023	Maestas Nicholas	officer	VP of Strategy and Finance	A-Award	Buy	100,000	$9.77	$977.00K	100,000
Jun 20, 2023	RAAB MICHAEL	director	-	A-Award	Buy	8,200	$1.42	$11.64K	8,200
Jun 20, 2023	NICHOL GEOFFREY	director	-	A-Award	Buy	8,200	$1.42	$11.64K	8,200
Jun 20, 2023	Pellizzari Christine A	director	-	A-Award	Buy	8,200	$1.42	$11.64K	8,200

The last insider sell of Tempest Therapeutics's stock was made by Versant Venture Capital VI, L.P. on Aug 12 2024, selling 400,000 shares at $1.35 per share (valued at $540.04K). The last insider buy of TPST was made by Brady Stephen R on Jul 08 2024, buying 35,000 shares at $2.11 per share (worth $73.85K).

Tempest Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	2	2	100.00%
Q2 2024	5	-	-
Q1 2024	4	-	-
Q4 2023	4	-	-
Q2 2023	4	-	-
Q1 2023	5	-	-
Q4 2022	1	-	-
Q3 2022	-	1	-
Q2 2022	14	1	1400.00%
Q1 2022	7	-	-
Q4 2021	-	-	-
Q3 2021	11	-	-
Q2 2021	24	1	2400.00%
Q1 2021	3	9	33.33%
Q2 2020	12	-	-
Q1 2020	6	-	-
Q4 2019	1	-	-
Q3 2019	2	3	66.67%
Q2 2019	9	-	-
Q1 2019	11	-	-

2 total buy trades, and 2 total sell trades (buy/sell ratio of 1.00%) were made by Tempest Therapeutics's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	2	2	100.00%
Q2 2024	1	-	-
Q1 2024	-	-	-
Q4 2023	-	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q3 2022	-	-	-
Q2 2022	1	-	-
Q1 2022	2	-	-
Q4 2021	-	-	-
Q3 2021	-	-	-
Q2 2021	-	-	-
Q1 2021	-	-	-
Q2 2020	-	-	-
Q1 2020	-	-	-
Q4 2019	-	-	-
Q3 2019	-	-	-
Q2 2019	-	-	-
Q1 2019	-	-	-

As of Q3 2024, Insider owners conducted 2 open market buy trades and 2 open market sell trades of Tempest Therapeutics's stocks.

Tempest Therapeutics Peer Ownership

Ticker	Company
OLMA	Olema Pharmaceuticals, Inc.
SANA	Sana Biotechnology, Inc.
CGEM	Cullinan Oncology, Inc.
ZNTL	Zentalis Pharmaceuticals, Inc.
RVMD	Revolution Medicines, Inc. Warrant
IKNA	Ikena Oncology, Inc.
SCPS	Scopus BioPharma Inc.
LYEL	Lyell Immunopharma, Inc.
AKTX	Akari Therapeutics, Plc
GLUE	Monte Rosa Therapeutics, Inc.
RNXT	RenovoRx, Inc.
RZLT	Rezolute, Inc.
INDP	Indaptus Therapeutics, Inc.
PCSA	Processa Pharmaceuticals, Inc.
ANEB	Anebulo Pharmaceuticals, Inc.
LIFE	aTyr Pharma, Inc.
CBIO	Gyre Therapeutics, Inc.
FBRX	Forte Biosciences, Inc.

TPST Ownership FAQ

Who Owns Tempest Therapeutics?

Tempest Therapeutics is owned by institutional shareholders (1.36%), insiders (0.24%), and public (98.40%). The largest institutional shareholder of Tempest Therapeutics is BLACKROCK INC. (2.47% of total shares) and the top mutual fund owner is FIDELITY COMMONWEALTH TRUST (0.00% of total shares).

Who are the major institutional shareholders of Tempest Therapeutics?

Tempest Therapeutics's major institutional shareholders are BLACKROCK INC., FMR LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and FIL LTD. The top five shareholders own together 6.49% of the company's share outstanding.

How many Tempest Therapeutics shareholders are there?

As of Jun 2024, there are 7 institutional shareholders of Tempest Therapeutics.

What percentage of Tempest Therapeutics is owned by BLACKROCK INC?

BLACKROCK INC owns 550.24K shares of Tempest Therapeutics, representing 2.47% of the company's total shares outstanding, valued at $1.21M (as of Jun 2024).

What percentage of Tempest Therapeutics is owned by FMR LLC?

As of Jun 2024, FMR LLC holds 431.93K shares of Tempest Therapeutics (TPST), compromising 1.94% of the company, valued at $945.93K.

What percentage of Tempest Therapeutics is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC is the third largest holder of Tempest Therapeutics. The company owns 176.19K of the company's shares outstanding (worth $385.86K).